82VS

82vs.com Direct investor

82VS is a venture studio embedded within Alloy Therapeutics that builds and supports asset-focused drug discovery companies. It provides portfolio companies access to Alloy's discovery platforms and services and supports them from concept through Series A.

82VS is a venture studio. It invests directly in companies, at Series A, in biotech, drug discovery, oncology and ophthalmology.

“82VS is a venture studio that builds capital efficient, asset focused drug companies by providing unique access to Alloy Therapeutics’ robust suite of discovery platforms and services across antibodies, bispecifics, TCR mimics, and genetic medicines.”

— 82VS, own website

Layer

Direct investor

Type

Venture studio

Stage

Series A

Sectors

biotech, drug discovery, oncology, ophthalmology, autoimmune, obesity, genetic medicines